Canadian Securities Exchange, Verdemed And Leafwire

The Canadian Securities Exchange (CSE) is the only exchange in Canada providing trading and market information services for all domestically listed instruments. Recognized as an exchange by the Ontario Securities Commission in 2004, the CSE is designed to facilitate the capital formation process for public companies through a streamlined approach to company regulation that emphasizes disclosure and the provision of efficient secondary market trading services for investors. The exchange is home to more than 230 issues covering a broad range of industry sectors. Verdemed is a Canadian pharmaceutical cannabis company whose goal is to improve the health of millions of patients in Latin America. Based in Toronto, Canada, Verdemed’s multi-level and multi-market approach aims to bridge the gap between the European and North American cannabis pharmaceutical landscape and Latin American unmet clinical needs. Leafwire exists to help usher in the new cannabis economy by educating and connecting the entrepreneurs and investors that will build this industry. 29 states and the District of Columbia have now legalized cannabis for medical and/or recreational purposes and public acceptance of cannabis continues to increase at a rapid pace. Cannabis has also shown encouraging signs as a treatment for various medical conditions and ailments, which should make the space of interest to investors and business enthusiasts. While cannabis remains federally illegal in the United States and publicly-traded cannabis companies are located overseas, it has grown to a $9 Billion industry in the U.S. and all estimates have it growing above $24 Billion over the next few years.